13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 42 holding rows worth $242,133,000.
- Accession
- 0001493152-22-032068
- Filer
- CIK 1595855
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 42 entries on the cover page, a total value of $242,133,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $242,132,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HARROW INC | 415858109 | COM | 3,343,817 | $40,360,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 6,465,000 | $26,830,000 | thousands by filing date | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 810,000 | $19,845,000 | thousands by filing date | |
| TELA BIO INC | 872381108 | COM | 2,036,551 | $17,351,000 | thousands by filing date | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 671,300 | $13,184,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 263,000 | $12,742,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 321,300 | $12,087,000 | thousands by filing date | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,708,067 | $7,993,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,155,000 | $6,999,000 | thousands by filing date | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 4,190,000 | $6,997,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 147,700 | $6,735,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 635,000 | $6,248,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 900,300 | $6,086,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 1,661,784 | $5,318,000 | thousands by filing date | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 2,521,000 | $5,294,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 292,700 | $5,254,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 253,200 | $5,072,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 190,000 | $4,560,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 248,000 | $4,442,000 | thousands by filing date | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 397,500 | $3,307,000 | thousands by filing date | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 563,500 | $3,065,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 350,700 | $2,820,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,556,800 | $2,802,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 2,999,000 | $2,579,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 3,115,000 | $2,318,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 577,250 | $1,830,000 | thousands by filing date | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 220,650 | $1,280,000 | thousands by filing date | |
| IMPEL PHARMACEUTICALS INC | 45258K109 | CMN | 255,250 | $1,243,000 | thousands by filing date | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 133,500 | $1,207,000 | thousands by filing date | |
| MODULAR MED INC | 60785L207 | COM NEW | 275,422 | $1,135,000 | thousands by filing date | |
| ALLAKOS INC | 01671P100 | COM | 153,500 | $939,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 365,000 | $704,000 | thousands by filing date | |
| JOURNEY MED CORP | 48115J109 | COM | 259,293 | $638,000 | thousands by filing date | |
| MORPHOSYS AG | 617760202 | ADR | 121,015 | $609,000 | thousands by filing date | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 71,300 | $588,000 | thousands by filing date | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 116,324 | $436,000 | thousands by filing date | |
| LUMOS PHARMA INC | 55028X109 | COM | 46,576 | $412,000 | thousands by filing date | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 575,000 | $368,000 | thousands by filing date | |
| OPTINOSE INC | 68404V100 | COM | 90,970 | $333,000 | thousands by filing date | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 10,000 | $84,000 | thousands by filing date | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,500 | $22,000 | thousands by filing date | |
| NULL | 09071M205 | NULL | 16,667 | $16,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-22-032068 | this filing | 2022-11-14 | acceptance time not in the bulk data set |